BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9700529)

  • 21. Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.
    Li RC; Lee SW; Kong CH
    J Antimicrob Chemother; 1997 Jul; 40(1):39-45. PubMed ID: 9249203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa.
    Park MK; Muhvich KH; Myers RA; Marzella L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):691-5. PubMed ID: 1906262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
    Ozbek B; Otuk G
    Chemotherapy; 2009; 55(6):446-50. PubMed ID: 19996590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.
    Rescott DL; Nix DE; Holden P; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):450-3. PubMed ID: 3288112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A; Mazzei T; Fallani S; Cassetta MI; Conti S
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperoxia and prolongation of aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa: role of reactive oxygen species.
    Park MK; Myers RA; Marzella L
    Antimicrob Agents Chemother; 1993 Jan; 37(1):120-2. PubMed ID: 8431008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):811-4. PubMed ID: 9222052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.
    Pastor A; Pemán J; Cantón E
    J Antimicrob Chemother; 1994 Nov; 34(5):679-85. PubMed ID: 7706163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.
    Maggiolo F; Taras A; Frontespezi S; Legnani MC; Silanos MA; Pravettoni G; Suter F
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1416-8. PubMed ID: 8092847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different patterns of bacterial DNA synthesis during postantibiotic effect.
    Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.
    Cao B; Christophersen L; Thomsen K; Sønderholm M; Bjarnsholt T; Jensen PØ; Høiby N; Moser C
    J Antimicrob Chemother; 2015 Jul; 70(7):2057-63. PubMed ID: 25786481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.
    Li RC; Tang MC
    J Antimicrob Chemother; 2005 Apr; 55(4):583-6. PubMed ID: 15728143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-antibacterial effect of thymol.
    Zarrini G; Delgosha ZB; Moghaddam KM; Shahverdi AR
    Pharm Biol; 2010 Jun; 48(6):633-6. PubMed ID: 20645735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A; Hay MB; Maier GA; Dyke JW
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.